Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Total Non-Current Liabilities (2023 - 2025)

Historic Total Non-Current Liabilities for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $67.6 million.

  • Metagenomi's Total Non-Current Liabilities fell 3208.94% to $67.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.6 million, marking a year-over-year decrease of 3208.94%. This contributed to the annual value of $87.7 million for FY2024, which is 3932.32% down from last year.
  • Metagenomi's Total Non-Current Liabilities amounted to $67.6 million in Q3 2025, which was down 3208.94% from $74.3 million recorded in Q2 2025.
  • Over the past 5 years, Metagenomi's Total Non-Current Liabilities peaked at $144.6 million during Q4 2023, and registered a low of $67.6 million during Q3 2025.
  • Over the past 3 years, Metagenomi's median Total Non-Current Liabilities value was $93.6 million (recorded in 2024), while the average stood at $100.5 million.
  • As far as peak fluctuations go, Metagenomi's Total Non-Current Liabilities tumbled by 3932.32% in 2024, and later plummeted by 3208.94% in 2025.
  • Metagenomi's Total Non-Current Liabilities (Quarter) stood at $144.6 million in 2023, then plummeted by 39.32% to $87.7 million in 2024, then dropped by 22.98% to $67.6 million in 2025.
  • Its Total Non-Current Liabilities was $67.6 million in Q3 2025, compared to $74.3 million in Q2 2025 and $83.1 million in Q1 2025.